AAAAAA
Results: 26-50/71
Authors:
RIZZO V
MEMMI M
MORATTI R
DERIL GM
PERUCCA E
Citation: V. Rizzo et al., CONCENTRATIONS OF L-DOPA IN PLASMA AND PLASMA ULTRAFILTRATES, Journal of pharmaceutical and biomedical analysis, 14(8-10), 1996, pp. 1043-1046
Authors:
TARTARA A
SARTORI I
MANNI R
GALIMBERTI CA
DIFAZIO M
PERUCCA E
Citation: A. Tartara et al., EFFICACY AND SAFETY OF TOPIRAMATE IN REFRACTORY EPILEPSY - A LONG-TERM PROSPECTIVE TRIAL, Italian journal of neurological sciences, 17(6), 1996, pp. 429-432
Authors:
SPINA E
PISANI F
PERUCCA E
Citation: E. Spina et al., CLINICALLY SIGNIFICANT PHARMACOKINETIC DRUG-INTERACTIONS WITH CARBAMAZEPINE - AN UPDATE, Clinical pharmacokinetics, 31(3), 1996, pp. 198-214
Authors:
PERUCCA E
BIALER M
Citation: E. Perucca et M. Bialer, THE CLINICAL PHARMACOKINETICS OF THE NEWER ANTIEPILEPTIC DRUGS - FOCUS ON TOPIRAMATE, ZONISAMIDE AND TIAGABINE, Clinical pharmacokinetics, 31(1), 1996, pp. 29-46
Authors:
PERUCCA E
Citation: E. Perucca, THE NEW-GENERATION OF ANTIEPILEPTIC DRUGS - ADVANTAGES AND DISADVANTAGES, British journal of clinical pharmacology, 42(5), 1996, pp. 531-543
Authors:
BARTOLI A
XIAODONG S
GATTI G
CIPOLLA G
MARCHISELLI R
PERUCCA E
Citation: A. Bartoli et al., THE INFLUENCE OF ETHNIC FACTORS AND GENDER ON CYP1A2-MEDIATED DRUG DISPOSITION - A COMPARATIVE-STUDY IN CAUCASIAN AND CHINESE SUBJECTS USING PHENACETIN AS A MARKER SUBSTRATE, Therapeutic drug monitoring, 18(5), 1996, pp. 586-591
Authors:
SPINA E
AVENOSO A
CAMPO GM
CAPUTI AP
PERUCCA E
Citation: E. Spina et al., PHENOBARBITAL INDUCES THE 2-HYDROXYLATION OF DESIPRAMINE, Therapeutic drug monitoring, 18(1), 1996, pp. 60-64
Authors:
MARCHIONI E
PERUCCA E
SORAGNA D
BO P
MALASPINA A
FERRANDI D
ALBERGATI A
SAVOLDI F
Citation: E. Marchioni et al., CHOREIFORM SYNDROME-ASSOCIATED WITH FLUOXETINE TREATMENT IN A PATIENTWITH DEFICIENT CYP2D6 ACTIVITY, Neurology, 46(3), 1996, pp. 853-853
Authors:
PERUCCA E
Citation: E. Perucca, PHARMACOKINETIC PROFILE OF TOPIRAMATE IN COMPARISON WITH OTHER NEW ANTIEPILEPTIC DRUGS, Epilepsia, 37, 1996, pp. 8-13
Authors:
MICHELUCCI R
CIPOLLA G
PASSARELLI D
GATTI G
OCHAN M
HEINIG R
TASSINARI CA
PERUCCA E
Citation: R. Michelucci et al., REDUCED PLASMA NISOLDIPINE CONCENTRATIONS IN PHENYTOIN-TREATED PATIENTS WITH EPILEPSY, Epilepsia, 37(11), 1996, pp. 1107-1110
Authors:
SPINA E
AVENOSO A
CAMPO GM
CAPUTI AP
PERUCCA E
Citation: E. Spina et al., THE EFFECT OF CARBAMAZEPINE ON THE 2-HYDROXYLATION OF DESIPRAMINE, Psychopharmacology, 117(4), 1995, pp. 413-416
Authors:
STABLES JP
BIALER M
JOHANNESSEN SI
KUPFERBERG HJ
LEVY RH
LOISEAU P
PERUCCA E
Citation: Jp. Stables et al., PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS A SUMMARY OF THE 2ND EILAT-CONFERENCE, Epilepsy research, 22(3), 1995, pp. 235-246
Authors:
PERUCCA E
POITOU P
PIFFERI G
Citation: E. Perucca et al., COMPARATIVE PHARMACOKINETICS AND BIOAVAILABILITY OF 2 ORAL FORMULATIONS OF THIOCOLCHICOSIDE, A GABA-MIMETIC MUSCLE-RELAXANT DRUG, IN NORMALVOLUNTEERS, European journal of drug metabolism and pharmacokinetics, 20(4), 1995, pp. 301-305
Authors:
PIFFERI G
PERUCCA E
Citation: G. Pifferi et E. Perucca, THE COST-BENEFIT RATIO OF ENANTIOMERIC DRUGS, European journal of drug metabolism and pharmacokinetics, 20(1), 1995, pp. 15-25
Authors:
PERUCCA E
Citation: E. Perucca, RATIONAL DRUG SELECTION IN ADULTS, Epilepsia, 36, 1995, pp. 89-89
Authors:
TARTARA A
SARTORI I
MANNI R
GALIMBERTI CA
DIFAZIO M
PERUCCA E
Citation: A. Tartara et al., ADD-ON TRIAL OF TOPIRAMATE IN REFRACTORY EPILEPSY, Epilepsia, 36, 1995, pp. 150-151
Authors:
BARTOLI A
GATTI G
BARZAGHI N
CIPOLLA G
VELIZ G
MUMFORD JP
PERUCCA E
Citation: A. Bartoli et al., VIGABATRIN DOES NOT AFFECT IN-VIVO PARAMETERS OF ENZYME-INDUCTION IN HUMANS, Epilepsia, 36, 1995, pp. 162-162
Authors:
PERUCCA E
Citation: E. Perucca, SHOULD WIDESPREAD COMPASSIONATE USE BEFORE REGISTRATION BE ALLOWED - A CONTRARY VIEW, Epilepsia, 36, 1995, pp. 217-217
Authors:
PISANI F
OTERI G
RUSSO M
TRIO R
DIPERRI R
PERUCCA E
RICHENS A
Citation: F. Pisani et al., EFFECTS OF LAMOTRIGINE-VALPROATE COMEDICATION ON SEIZURE FREQUENCY AND UPPER-LIMB TREMOR - A PHARMACODYNAMIC INTERACTION, Epilepsia, 36, 1995, pp. 264-264
Authors:
BEGHI E
PERUCCA E
Citation: E. Beghi et E. Perucca, THE MANAGEMENT OF EPILEPSY IN THE 1990S - ACQUISITIONS, UNCERTAINTIESAND PRIORITIES FOR FUTURE-RESEARCH, Drugs, 49(5), 1995, pp. 680-694
Authors:
PERUCCA E
Citation: E. Perucca, PHARMACOLOGICAL PRINCIPLES AS A BASIS FOR POLYTHERAPY, Acta neurologica Scandinavica, 92, 1995, pp. 31-34
Authors:
SILFVENIUS H
HALASZ P",ROSCISZEWSKA,"HAUSER WA",STELMASIAK,"SCHMIDT D
PITKANEN A
MATTSON RH",MARROSU,"RICHENS A
PERUCCA E
YLINEN A
DEBITTENCOURT PRM
Citation: H. Silfvenius et al., THE RATIONAL MANAGEMENT OF EPILEPSY THROUGH GREATER UNDERSTANDING OF THE DISEASE - DISCUSSION, Acta neurologica Scandinavica, 92, 1995, pp. 51-55
Authors:
SPINA E
PERUCCA E
Citation: E. Spina et E. Perucca, NEWER AND OLDER ANTIDEPRESSANTS - A COMPARATIVE REVIEW OF DRUG-INTERACTIONS, CNS DRUGS, 2(6), 1994, pp. 479-497
Authors:
SPINA E
CAMPO GM
AVENOSO A
CAPUTI AP
ZUCCARO P
PACIFICI R
GATTI G
STRADA G
BARTOLI A
PERUCCA E
Citation: E. Spina et al., CYP2D6-RELATED OXIDATION POLYMORPHISM IN ITALY, Pharmacological research, 29(3), 1994, pp. 281-289
Authors:
GATTI G
PERUCCA E
Citation: G. Gatti et E. Perucca, PLASMA-CONCENTRATIONS OF FREE AND CONJUGATED SILYBIN AFTER ORAL INTAKE OF A SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX (SILIPIDE) IN HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 32(11), 1994, pp. 614-617